The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...
With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.
The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.
Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.
Moderna (MRNA) announced on Wednesday that it has completed its domestic end-to-end mRNA manufacturing network with the ...
More than three-quarters of American adults didn't get a COVID shot last season, a figure that health care experts warn could ...
Grim revelations have surfaced from within the Department of Health and Human Services (HHS), exposing a culture of censorship surrounding critical discussions about the COVID-19 vaccine and its ...
Delaware says COVID-19 vaccines are available at state clinics, regardless of insurance status. But only 2 clinics carried ...
The oropharyngeal cancer market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as PDS Biotechnology's Versamune HPV, Inovio ...
Jacobin on MSNOpinion
How Big Pharma Turned FDA Approval Into a Rubber Stamp
Alberto Espay was not prepared for how his world would be upended when he published a study on the number of people who have ...
The company posted a net loss of 51 cents a share, against Wall Street’s expectation for a loss of $2.21. Moderna has ...
Moderna lowered the top end of its 2025 revenue forecast by $200 million on Thursday, citing weaker-than-expected sales of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback